University College London And Takeda Announce A New Research Partnership To Identify Novel Therapeutic Targets For Neurodegenerative Diseases

LONDON & CAMBRIDGE, England--(BUSINESS WIRE)--UCL (University College London) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced a new research collaboration to identify and validate novel target genes for the treatment of neurodegenerative disease.

Help employers find you! Check out all the jobs and post your resume.